Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2016-11-16

Clinical Trial Update: The Effect of Ultra-low-dose Naloxone on Remifentanil-induced Postoperative Hyperalgesia - A Randomized Controlled Study [NA]

View source ↗

Summary

This completed randomized controlled trial evaluated whether ultra-low-dose naloxone can reduce remifentanil-induced postoperative hyperalgesia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Naloxone (Naloxone)
  • Remifentanil (remifentanil)

Snippet

Sponsor: Seoul National University Hospital | Conditions: Pain | NA | Status: COMPLETED